HIV Coinfection

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HIV Coinfection trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 10 trials

RecruitingNot Applicable

NCT07487350

Recurrent Visceral Leishmaniasis in HIV Co-Infection

The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients livin…

Ethiopia20 participantsStarted 2025-10-21

RecruitingNot Applicable

NCT07429864

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

HDV is an RNA virus that infects only in the presence of HBV, affecting about 13% of HBsAg carriers. In Italy, prevalence ranges from 3.2% to 9.3%. It increases…

Italy20 participantsStarted 2025-09-24

RecruitingNot Applicable

NCT07209917

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

Cervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable…

India420 participantsStarted 2026-02-01

Treatment: ASHA-Health HPV Intervention, Enhanced Standard of Care (SOC+)

RecruitingNot Applicable

NCT05553236

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

TS ELiOT is a stepped-wedge, cluster randomized trial assessing the effect of a next-generation sequencing-based strategy on rifampin-resistant tuberculosis man…

South Africa2,500 participantsStarted 2024-08-01

Treatment: Targeted next-generation sequencing

RecruitingNot Applicable

NCT05342064

Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service

Tuberculosis (TB) is the world's leading infectious cause of mortality and responsible for 1/3 of deaths in people living with human immunodeficiency virus (PLH…

Eswatini, Lesotho +3 more6,500 participantsStarted 2023-07-11

Treatment: patient-centered TB preventive therapy, TB preventive therapy adherence support

RecruitingNot Applicable

NCT06889805

HDV Screening Study

This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.

Hong Kong300 participantsStarted 2025-02-15

All recent trials (100 shown)

CompletedPhase 2

NCT06144086

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

This is a phase 2 trial of foscenvivint in liver cirrhosis patients caused by HIV/HCV co-infection with hemophilia to evaluate the efficacy, safety and pharmaco…

Japan5 participantsStarted 2024-05-08

Treatment: Foscenvivint

CompletedPhase 2

NCT04930744

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

The METHOD study will examine whether adding metformin to standard antibiotic treatment for tuberculosis (TB) in people with HIV is safe and well tolerated. The…

South Africa112 participantsStarted 2021-08-26

Treatment: Isoniazid, Rifampicin

HIV Coinfection

Trial phase breakdown

Trial status

Actively recruiting — 10 trials

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service

HDV Screening Study

All recent trials (100 shown)

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

Trial phase breakdown

Trial status

Actively recruiting — 10 trials

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis

Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service

HDV Screening Study

All recent trials (100 shown)

A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living…

Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection

Pharmacist-Led Intervention to Improve TB Treatment Adherence

Towards a Functional Cure for HBV - The COMMIT Cohort Study

HIV And Parasitic Infection (HAPI) Study

Supporting Treatment Outcomes Among PWID

TB-CAPT EXULTANT - HIV

Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis

HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies…

Zepatier in Patients with Substance Use

COVID-19 Serology in People Living with HIV in Hong Kong

Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet

Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.

Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection